Phase 2 trials of linifanib (ABT-869) in advanced hepatocellular, renal cell and non-small cell lung cancer: Associations of response by CT or DCE-MRI with patient outcome

被引：1
|
作者：
Toh, Han Chong
Yong, Wei Peng
Wang, Yu-Ning
Tan, Eng-Huat
Kollmannsberger, Christian K.
Devanarayan, Viswanath
Zhang, Ke
Luo, Yanping
Chen, Daniel
Ashton, Edward
Ricker, Justin L.
Carlson, Dawn
Chen, Pei-Jer
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-A105
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A105
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Phase 2 Trial of Linifanib (ABT-869) in Patients with Advanced Non-small Cell Lung Cancer
    Tan, Eng-Huat
    Goss, Glenwood D.
    Salgia, Ravi
    Besse, Benjamin
    Gandara, David R.
    Hanna, Nasser H.
    Yang, James Chih-Hsin
    Thertulien, Raymond
    Wertheim, Michael
    Mazieres, Julien
    Hensing, Thomas
    Lee, Christa
    Gupta, Neeraj
    Pradhan, Rajendra
    Qian, Jiang
    Qin, Qin
    Scappaticci, Frank A.
    Ricker, Justin L.
    Carlson, Dawn M.
    Soo, Ross A.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (08) : 1418 - 1425
  • [2] Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure
    Tannir, Nizar M.
    Wong, Yu-Ning
    Kollmannsberger, Christian K.
    Ernstoff, Marc S.
    Perry, David J.
    Appleman, Leonard J.
    Posadas, Edwin M.
    Cho, Daniel
    Choueiri, Toni K.
    Coates, Andrew
    Gupta, Neeraj
    Pradhan, Rajendra
    Qian, Jiang
    Chen, Jihong
    Scappaticci, Frank A.
    Ricker, Justin L.
    Carlson, Dawn M.
    Michaelson, M. Dror
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (18) : 2706 - 2714
  • [3] ABT-869 response monitoring with DCE-MRI, PET and CT imaging in advanced solid tumor cancer patients
    Steinberg, Joyce
    Ricker, Justin
    Wong, Yu-Ning
    Tan, Eng-Huat
    Toh, Han Chong
    Kollmannsberger, Christian
    Qian, Jane
    Ashton, Edward
    Carlson, Dawn
    CANCER RESEARCH, 2009, 69
  • [4] ABT-869 in non-small cell lung cancer (NSCLC): Interim results
    Tan, E.
    Salgia, R.
    Besse, B.
    Goss, G.
    Gandara, D. R.
    Hanna, N.
    Steinberg, J.
    Steinberg, J.
    Qian, J.
    Carlson, D. M.
    Soo, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft model
    Sarah R. Mudd
    Martin J. Voorbach
    David R. Reuter
    Paul Tapang
    Jonathan A. Hickson
    Marion Refici-Buhr
    Gerard B. Fox
    Daniel H. Albert
    Yanping Luo
    Mark Day
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1669 - 1672
  • [6] FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft model
    Mudd, Sarah R.
    Voorbach, Martin J.
    Reuter, David R.
    Tapang, Paul
    Hickson, Jonathan A.
    Refici-Buhr, Marion
    Fox, Gerard B.
    Albert, Daniel H.
    Luo, Yanping
    Day, Mark
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (06) : 1669 - 1672
  • [7] Phase II results of ABT-869 treatment in patients with non small cell lung cancer (NSCLC)
    Tan, E.
    Goss, G.
    Salgia, R. R.
    Besse, B.
    Gandara, D. R.
    Hanna, N.
    Ricker, J. L.
    Qian, J.
    Carlson, D. M.
    Soo, R.
    EJC SUPPLEMENTS, 2009, 7 (02): : 509 - 510
  • [8] Phase 2 results of ABT-869 treatment in patients with advanced renal cell cancer (RCC) after sunitinib failure
    Tannir, N.
    Wong, Y.
    Kollmannsberger, C.
    Ernstoff, M. S.
    Perry, D. J.
    Appleman, L. J.
    Posadas, E.
    Qian, J.
    Ricker, J. L.
    Michaelson, D. M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 425 - 425
  • [9] Phase 2 study of ABT-869 in combination with Carboplatin/Paclitaxel (CP) in patients with advanced or metastatic Non-Small Cell Lung Cancer (NSCLC): lead-in cohort results
    Ramalingam, Suresh
    Owonikoko, Taofeek
    Khuri, Fadlo
    Saba, Nabil
    Wallace, James
    Qian, Jiang
    Gupta, Neeraj
    Ricker, Justin
    Carlson, Dawn
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S706 - S706
  • [10] Assessment of pharmacokinetic (PK) interactions between Carboplatin (C), Paclitaxel (P) and ABT-869 in patients with advanced or metastatic non-small cell lung cancer (NSCLC)
    Gupta, Neeraj
    Palaparthy, Rameshraja
    Awni, Walid
    Carlson, Dawn
    Pradhan, Rajendra
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S669 - S669
12345